Oncologist-approved cancer information from the American Society of Clinical Oncology
Printer Friendly
Download PDF

Waldenström's Macroglobulinemia

This section has been reviewed and approved by the Cancer.Net Editorial Board, 9/2013
Statistics

ON THIS PAGE: You will find information about how many people learn they have this type of cancer each year and some general survival information. Remember, survival rates depend on several factors. To see other pages, use the menu on the side of your screen.

Waldenström’s macroglobulinemia is uncommon. Each year, an estimated 1,000 to 1,500 adults in the United States are diagnosed with Waldenström’s macroglobulinemia. The chance of developing Waldenström’s macroglobulinemia increases as people age, and the average age people are diagnosed with Waldenström’s macroglobulinemia is in the late 60s or early 70s.

The five-year survival rate is the percentage of people who survive at least five years after the cancer is detected, excluding those who die from other diseases. The five-year survival rate of people with Waldenström’s macroglobulinemia is about 70%. However, it is important to note that survival rates vary based on a number of individual factors, including the patient’s age, how much the disease has spread at the time of diagnosis, and whether the patient has other medical problems.

Cancer survival statistics should be interpreted with caution. These estimates are based on data from thousands of people with this type of cancer in the United States, but the actual risk for a particular individual may differ. It is not possible to tell a person how long he or she will live with Waldenström’s macroglobulinemia. Learn more about understanding statistics.

Statistics from the American Cancer Society.

To continue reading this guide, use the menu on the side of your screen to select another section.  

© 2005-2014 American Society of Clinical Oncology (ASCO). All rights reserved worldwide.

Connect With Us: